rexahn – HedgeChatter

Capitalize on Comeback Stories in Micro-Cap Biotech Stocks :: The …

Capitalize on Comeback Stories in Micro-Cap Biotech StocksCompanies / BioTechJun 17, 2015 – 09:55 PM GMTBy: TLSReportThe list of problems with investing in micro-cap biotech stocks begins with extreme volatility and lack of liquidity and ends with the inability to get validation from sophisticated investors who are unable to own such small companies. Nevertheless, sift through the pile and investors […]

Select 2015 Stem Cell Company Catalysts: Sagient Research’s Edward Stopke

Under agreement with StreetWise Reports, I’m pleased to share their recent coverage of the regenerative medicine sector.Original Source: Source: Peter Byrne of The Life Sciences Report (1/22/15)”Convert Catalysts into Profits: Sagient Research’s Edward Stopke“The biotech sector is teeming with companies racing to bring the hot new drug or therapy to the marketplace. But realistically assessing the therapeutic potential of pipeline […]